Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313461130> ?p ?o ?g. }
- W4313461130 endingPage "109649" @default.
- W4313461130 startingPage "109649" @default.
- W4313461130 abstract "Molecular therapy refers to targeted therapies based on molecules which have been intelligently directed towards specific biomolecular structures and include small molecule drugs, monoclonal antibodies, proteins and peptides, DNA or RNA-based strategies, targeted chemotherapy and nanomedicines. Molecular therapy is emerging as the most effective strategy to combat the present challenges of life-threatening visceral leishmaniasis, where the successful human vaccine is currently unavailable. Moreover, current chemotherapy-based strategies are associated with the issues of ineffective targeting, unavoidable toxicities, invasive therapies, prolonged treatment, high treatment costs and the development of drug-resistant strains. Thus, the rational approach to antileishmanial drug development primarily demands critical exploration and exploitation of biochemical differences between host and parasite biology, immunocharacteristics of parasite homing, and host-parasite interactions at the molecular/cellular level. Following this, the novel technology-based designing and development of host and/or parasite-targeted therapeutics having leishmanicidal and immunomodulatory activity is utmost essential to improve treatment efficacy. Thus, the present review is focused on immunological and molecular checkpoint targets in host-pathogen interaction, and molecular therapeutic prospects for Leishmania intervention, and the challenges ahead." @default.
- W4313461130 created "2023-01-06" @default.
- W4313461130 creator A5000759047 @default.
- W4313461130 creator A5006519161 @default.
- W4313461130 creator A5050743019 @default.
- W4313461130 creator A5067255118 @default.
- W4313461130 creator A5069897004 @default.
- W4313461130 creator A5075946768 @default.
- W4313461130 creator A5086747343 @default.
- W4313461130 date "2023-02-01" @default.
- W4313461130 modified "2023-10-14" @default.
- W4313461130 title "Emerging strategies and challenges of molecular therapeutics in antileishmanial drug development" @default.
- W4313461130 cites W107280473 @default.
- W4313461130 cites W1491819291 @default.
- W4313461130 cites W1494347482 @default.
- W4313461130 cites W1500203742 @default.
- W4313461130 cites W1514902632 @default.
- W4313461130 cites W1532865172 @default.
- W4313461130 cites W1593264128 @default.
- W4313461130 cites W1599803648 @default.
- W4313461130 cites W1673767569 @default.
- W4313461130 cites W1674844815 @default.
- W4313461130 cites W1752411429 @default.
- W4313461130 cites W1753616956 @default.
- W4313461130 cites W1818989087 @default.
- W4313461130 cites W1895190820 @default.
- W4313461130 cites W1899319151 @default.
- W4313461130 cites W1903629244 @default.
- W4313461130 cites W1965454317 @default.
- W4313461130 cites W1971130277 @default.
- W4313461130 cites W1971661467 @default.
- W4313461130 cites W1972097531 @default.
- W4313461130 cites W1972806542 @default.
- W4313461130 cites W1973007471 @default.
- W4313461130 cites W1974917546 @default.
- W4313461130 cites W1975224351 @default.
- W4313461130 cites W1975273440 @default.
- W4313461130 cites W1975581657 @default.
- W4313461130 cites W1975614186 @default.
- W4313461130 cites W1976039079 @default.
- W4313461130 cites W1979152114 @default.
- W4313461130 cites W1979353967 @default.
- W4313461130 cites W1980929124 @default.
- W4313461130 cites W1982353608 @default.
- W4313461130 cites W1983744287 @default.
- W4313461130 cites W1983956209 @default.
- W4313461130 cites W1984206095 @default.
- W4313461130 cites W1985622878 @default.
- W4313461130 cites W1986686460 @default.
- W4313461130 cites W1986819368 @default.
- W4313461130 cites W1989296289 @default.
- W4313461130 cites W1989310953 @default.
- W4313461130 cites W1989467189 @default.
- W4313461130 cites W1990066101 @default.
- W4313461130 cites W1992857382 @default.
- W4313461130 cites W1995127073 @default.
- W4313461130 cites W2001824475 @default.
- W4313461130 cites W2002017125 @default.
- W4313461130 cites W2003948064 @default.
- W4313461130 cites W2004248893 @default.
- W4313461130 cites W2004465286 @default.
- W4313461130 cites W2006626597 @default.
- W4313461130 cites W2007520264 @default.
- W4313461130 cites W2008224161 @default.
- W4313461130 cites W2012285734 @default.
- W4313461130 cites W2023445327 @default.
- W4313461130 cites W2023520453 @default.
- W4313461130 cites W2024029097 @default.
- W4313461130 cites W2024303872 @default.
- W4313461130 cites W2024396003 @default.
- W4313461130 cites W2026286437 @default.
- W4313461130 cites W2028090721 @default.
- W4313461130 cites W2028354883 @default.
- W4313461130 cites W2028889133 @default.
- W4313461130 cites W2029306217 @default.
- W4313461130 cites W2029542316 @default.
- W4313461130 cites W2030520525 @default.
- W4313461130 cites W2030982793 @default.
- W4313461130 cites W2033947274 @default.
- W4313461130 cites W2036064234 @default.
- W4313461130 cites W2036537260 @default.
- W4313461130 cites W2040231972 @default.
- W4313461130 cites W2041202357 @default.
- W4313461130 cites W2041445698 @default.
- W4313461130 cites W2041696819 @default.
- W4313461130 cites W2043964141 @default.
- W4313461130 cites W2047573521 @default.
- W4313461130 cites W2049977846 @default.
- W4313461130 cites W2051740720 @default.
- W4313461130 cites W2052340028 @default.
- W4313461130 cites W2055079338 @default.
- W4313461130 cites W2055583123 @default.
- W4313461130 cites W2056515488 @default.
- W4313461130 cites W2056538642 @default.
- W4313461130 cites W2057260347 @default.
- W4313461130 cites W2057811708 @default.
- W4313461130 cites W2059299190 @default.
- W4313461130 cites W2059322072 @default.